Ambrose Healthcare is a specialist pharmaceutical company, developing new treatments for rare diseases and patients managed in hospitals and specialist care.



The company has an experienced leadership team with deep knowledge of the pharmaceutical industry and a track record of success, supported by an international network of rare disease experts and organisations.



Ambrose Healthcare is focused on acquiring late stage drug assets with a minimum of Phase 2 data and that have novel applications in rare diseases.



Ambrose Healthcare is working towards becoming a centre of excellence and a premier rare disease company. Read more on the company’s approach in its recently published white paper: https://ambrosehc.com/wp-content/uploads/2023/11/Ambrose-HC-New-opportunities-in-rare-disease-drug-treatment_Nov-2023.pdf